FBRX Financials: Forte Biosciences Inc AI Analysis

Home

Stock

FBRX

Financials

FBRX Financial

Forte Biosciences Inc

$26.27

0.38%

$0.09

At close: Apr 08, 16:00:00 GMT-4

$26.65

1.44%

$0.37

Post-market: Apr 08, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$26.17

Open

$26.98

Day's Range

$25.31 - $28.1

52 week range

$4.9 - $35.62

Volume

109.1K

Avg.Volume

228.5K

Dividend yield

EPS (TTM)

-4.49

Market Cap

$333.9M

What is FBRX?

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The company is headquartered in Dallas, Texas and currently employs 14 full-time employees. The company went IPO on 2017-04-13. The company is advancing clinical development of FB102 into patient-based trials for celiac disease and non-segmental vitiligo. The firm's FB102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and certain T cell subsets. FB102 has potentially other autoimmune and autoimmune-related applications including vitiligo, alopecia areata, and type 1 diabetes (T1D). Its subsidiaries include Forte Subsidiary, Inc. and Forte Biosciences Australia Proprietary Limited.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

FBRX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	12	12	15	10	8	7
Research & Development	58	58	21	21	5	13
Operating Expenses	70	70	36	32	13	21
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-68	-68	-35	-31	-13	-21
Income Tax Expense	1	1	--	--	--	--
Net Income	-69	-69	-35	-31	-13	-21
Net Income Growth	97%	97%	13%	138%	-38%	-54%
Shares Outstanding (Diluted)	17.86	14.71	2.91	1.26	17.38	13.97
Shares Change (YoY)	192%	405%	131%	-93%	24%	90%
EPS (Diluted)	-3.88	-4.71	-12.16	-24.92	-0.8	-1.55
EPS Growth	-34%	-61%	-51%	3,016%	-48%	-75%
Free Cash Flow	-50	-50	-30	-28	-8	-16
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-70	-70	-36	-32	-13	-21
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-70	-70	-36	-32	-13	-21
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	-1.47%	-1.47%	--	--	--	--

Follow-Up Questions

What are Forte Biosciences Inc's key financial statements?



According to the latest financial statement (Form-10K), Forte Biosciences Inc has a total asset of $82, Net loss of $-69

What are the key financial ratios for FBRX?



Forte Biosciences Inc's Current ratio is 3.9, has a Net margin is 0, sales per share of $0.

How is Forte Biosciences Inc's revenue broken down by segment or geography?



Forte Biosciences Inc largest revenue segment is Photovoltaic Modules, at a revenue of 3,827,135,768 in the most earnings release.For geography, China is the primary market for Forte Biosciences Inc, at a revenue of 3,439,789,194.

Is Forte Biosciences Inc profitable?



no, according to the latest financial statements, Forte Biosciences Inc has a net loss of $-69

Does Forte Biosciences Inc have any liabilities?



yes, Forte Biosciences Inc has liability of 21

How many outstanding shares for Forte Biosciences Inc?



Forte Biosciences Inc has a total outstanding shares of 12.94

Forte Biosciences Inc (FBRX) Financial

FBRX Stock Price Chart